$4.49 shipping anywhere in the 50 states and DC · free from $32 · every copy new

Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies

Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies

In stock
$29.00
Book FormatEbook
1
SKU:GC-7245144743
Comes to you in 4-8 business days though delays can occur.
Return your order within 30 days from delivery.
Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies

Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies

$29.00

A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed.

Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option. Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.

Book Details

  • Author: Michael W. Stewart
  • Publisher: Adis
  • eBook ISBN: 9789811035098, 9811035091
  • Print ISBN: 9789811035081, 9811035083

Product Details

TypeBook
SKUGC-7245144743-BOOK
TagsNew Book, Health & Medicine

You May Also Like

View all →